Preventing hypoglycaemia by heavily reducing pre- and post-exercise rapid-acting insulin dose may cause hyperglycaemia, but not hyperketonaemia in type 1 diabetes patients

被引：0
|
作者：
Campbell, M. D. [1 ]
Walker, M. [2 ]
Trenell, M. I. [3 ]
Luzio, S. [4 ]
Dunseath, G. [4 ]
Stevenson, E. J. [1 ]
Bracken, R. M. [5 ]
Turner, D. [5 ]
Bain, S. C. [4 ]
West, D. J. [1 ]
机构：
[1] Northumbria Univ, Dept Sport Exercise & Rehabil, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England
[2] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[3] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[4] Swansea Univ, Diabet Res Grp, Swansea, W Glam, Wales
[5] Swansea Univ, Coll Engn, Swansea, W Glam, Wales
来源：
DIABETOLOGIA | 2013年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
685
引用
收藏
页码：S277 / S278
页数：2
相关论文
共 39 条
  • [21] Reduction in insulin dose and body weight with pre- and post-meal insulin glulisine (GLU) versus regular human insulin (RHI) in patients with type 1 diabetes
    Garg, S
    Chen, YP
    Souhami, E
    DIABETES, 2005, 54 : A144 - A144
  • [22] Insulin dose and weight profiles of pre- and post-meal insulin glutisine (GLU) in a basal-bolus regimen with insulin glargine in patients with type 1 diabetes
    Garg, S
    Rosenstock, J
    Ways, K
    DIABETES, 2004, 53 : A125 - A126
  • [23] Similar Variability in Pre- and Post-exercise Glucose Levels between Morning-Fasted and Afternoon-Fed Resistance Exercise in Adults with Type 1 Diabetes
    Mcclure, Reid
    Nitz, Corbin J.
    Yardley, Jane E.
    DIABETES, 2023, 72
  • [24] Persistence with rapid-acting insulin and its association with A1C level and severe hypoglycemia among elderly patients with type 2 diabetes
    Sambamoorthi, Usha
    Garg, Rahul
    Deb, Arijita
    Fan, Tao
    Boss, Anders
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (07) : 1309 - 1316
  • [25] Impact of pre- and post-exercise strategies on hypoglycemic risk for two modalities of aerobic exercise among adults and adolescents living with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized controlled trial
    Molveau, Josephine
    Myette-Cote, Etienne
    Guedet, Capucine
    Tagougui, Semah
    St-Amand, Roxane
    Suppere, Corinne
    Heyman, Elsa
    Messier, Virginie
    Boudreau, Valerie
    Legault, Laurent
    Rabasa-Lhoret, Remi
    DIABETES & METABOLISM, 2025, 51 (01)
  • [26] Similar A1C outcomes in type 1 diabetic patients undergoing intensive diabetes management with preprandial rapid-acting insulin and either CSII or glargine
    Harmel, AP
    Mathur, R
    DIABETES CARE, 2004, 27 (01) : 272 - 273
  • [27] Administering a small rapid-acting insulin bolus 3 h after eating a mixed macronutrient meal improves postprandial glucose control, without hypoglycaemia, in people with Type 1 diabetes
    Campbell, M. D.
    Walker, M.
    King, D.
    Allerton, D.
    Shaw, J. A.
    Luzio, S.
    Dunseath, G.
    Bracken, R. M.
    Stevenson, E. J.
    West, D. J.
    DIABETIC MEDICINE, 2016, 33 : 109 - 109
  • [28] Reduced risk of early-onset but not late-onset post-exercise hypoglycaemia following intermittent games-type activity in Type 1 diabetes patients
    Campbell, M. D.
    West, D. J.
    Bain, S. C.
    Kingsley, M. I. C.
    Foley, P.
    Turner, D.
    Gray, B. J.
    Stephens, J. W.
    Bracken, R. M.
    DIABETIC MEDICINE, 2014, 31 : 69 - 69
  • [29] Comparative Effectiveness of Various Long-Acting (Lantus, Levemir), Rapid-Acting (Apidra, Humalog, Novalog) Insulin Analogs and Their Combinations for Type 1 Diabetes (T1D) Patients
    Woodwyk, Alyssa
    Beam, Craig
    DIABETES, 2016, 65 : A253 - A253
  • [30] Glucagon-like peptide 1 receptor agonist or rapid-acting insulin as add-on to basal insulin therapy in patients with type 2 diabetes mellitus: a meta-analysis
    Kuritzky, L.
    Lin, J.
    Wysham, C. H.
    DIABETOLOGIA, 2015, 58 : S384 - S384
1234